Literature DB >> 32702208

Anticoagulant protein S-New insights on interactions and functions.

Magdalena Gierula1, Josefin Ahnström1.   

Abstract

Protein S is a critical regulator of coagulation that functions as a cofactor for the activated protein C (APC) and tissue factor pathway inhibitor (TFPI) pathways. It also has direct anticoagulant functions, inhibiting the intrinsic tenase and prothrombinase complexes. Through these functions, protein S regulates coagulation during both its initiation and its propagation phases. The importance of protein S in hemostatic regulation is apparent from the strong association between protein S deficiencies and increased risk for venous thrombosis. This is most likely because both APC and TFPIα are inefficient anticoagulants in the absence of any cofactors. The detailed molecular mechanisms involved in protein S cofactor functions remain to be fully clarified. However, recent advances in the field have greatly improved our understanding of these functions. Evidence suggests that protein S anticoagulant properties often depend on the presence of synergistic cofactors and the formation of multicomponent complexes on negatively charged phospholipid surfaces. Their high affinity binding to negatively charged phospholipids helps bring the anticoagulant proteins to the membranes, resulting in efficient and targeted regulation of coagulation. In this review, we provide an update on protein S and how it functions as a critical hemostatic regulator.
© 2020 International Society on Thrombosis and Haemostasis.

Entities:  

Keywords:  activated protein C; anticoagulant; factor V; protein S

Mesh:

Substances:

Year:  2020        PMID: 32702208     DOI: 10.1111/jth.15025

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  7 in total

Review 1.  Illustrated State-of-the-Art Capsules of the ISTH 2022 Congress.

Authors:  Robert A Ariëns; Beverley J Hunt; Ejaife O Agbani; Josefin Ahnström; Robert Ahrends; Raza Alikhan; Alice Assinger; Zsuzsa Bagoly; Alessandra Balduini; Elena Barbon; Christopher D Barrett; Paul Batty; Jorge David Aivazoglou Carneiro; Wee Shian Chan; Moniek de Maat; Kerstin de Wit; Cécile Denis; Martin H Ellis; Renee Eslick; Hongxia Fu; Catherine P M Hayward; Benoit Ho-Tin-Noé; Frederikus A Klok; Riten Kumar; Karin Leiderman; Rustem I Litvinov; Nigel Mackman; Zoe McQuilten; Matthew D Neal; William A E Parker; Roger J S Preston; Julie Rayes; Alireza R Rezaie; Lara N Roberts; Bianca Rocca; Susan Shapiro; Deborah M Siegal; Lirlândia P Sousa; Katsue Suzuki-Inoue; Tahira Zafar; Jiaxi Zhou
Journal:  Res Pract Thromb Haemost       Date:  2022-07-06

2.  Rapid identification of a pathogenic variant of PROS1 in a thrombophilic family by whole exome sequencing: A case report.

Authors:  Wenwen Zhang; Chen Huang; Wei Zhou
Journal:  Medicine (Baltimore)       Date:  2021-12-30       Impact factor: 1.889

Review 3.  The enzymes in COVID-19: A review.

Authors:  Maria Helena Menezes Estevam Alves; Layla Carvalho Mahnke; Tifany Cerqueira Macedo; Thais Ketinly Dos Santos Silva; Luiz Bezerra Carvalho Junior
Journal:  Biochimie       Date:  2022-01-26       Impact factor: 4.372

4.  Laminin G1 residues of protein S mediate its TFPI cofactor function and are competitively regulated by C4BP.

Authors:  Adrienn Teraz-Orosz; Magdalena Gierula; Anastasis Petri; David Jones; Renos Keniyopoullos; Patricia Badia Folgado; Salvatore Santamaria; James T B Crawley; David A Lane; Josefin Ahnström
Journal:  Blood Adv       Date:  2022-01-25

5.  An engineered activated factor V for the prevention and treatment of acute traumatic coagulopathy and bleeding in mice.

Authors:  Bilgimol Chumappumkal Joseph; Byron Y Miyazawa; Charles T Esmon; Mitchell J Cohen; Annette von Drygalski; Laurent O Mosnier
Journal:  Blood Adv       Date:  2022-02-08

6.  Protein S Deficiency and the Risk of Venous Thromboembolism in the Han Chinese Population.

Authors:  Yingying Wu; Jingdi Liu; Wei Zeng; Bei Hu; Yu Hu; Liang V Tang
Journal:  Front Cardiovasc Med       Date:  2022-06-23

7.  A hydrophobic patch (PLVIVG; 1481-1486) in the B-domain of factor V-short is crucial for its synergistic TFPIα-cofactor activity with protein S and for the formation of the FXa-inhibitory complex comprising FV-short, TFPIα, and protein S.

Authors:  Björn Dahlbäck; Sinh Tran
Journal:  J Thromb Haemost       Date:  2022-03-16       Impact factor: 16.036

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.